|
Edoxaban iMpurities
|
依度沙班雜質(zhì)
|
1255529-34-0
|
|
EveroliMus iMpurity
|
依維莫司雜質(zhì)
|
1661009-29-5
|
|
Cefoxitin Impurity
|
頭孢西丁雜質(zhì)
|
|
|
Canagliflozin iMpurity
|
卡格列凈雜質(zhì)
|
|
|
Erythromycin Impurity
|
紅霉素雜質(zhì)
|
40554-78-7
|
|
Linagliptin iMpurity
|
利拉利汀雜質(zhì)
|
2140263-92-7
|
|
Cinacalcet IMpurity
|
西那卡塞雜質(zhì)
|
1229224-93-4
|
|
N,N'-Desethylene-N,N'-diforMyl Levofloxacin
|
左氧氟沙星雜質(zhì)
|
151377-74-1
|
|
AMlodipine iMpurity
|
氨氯地平雜質(zhì)
|
|
|
BroMhexine Hydrochloride iMpurity DN-(2-AMino-5-broMobenzyl)-N-MethylcyclohexanaMine Dihydrochloride
|
溴己新雜質(zhì)
|
132004-28-5
|
|
LevetiracetaM IMurity (L-2-AMinobutanaMide HCl,S-2-AMinobutanaMide HCl)
|
左乙拉西坦雜質(zhì)
|
1933471-30-7
|
|
Trelagliptin IMpurity
|
曲格列汀雜質(zhì)
|
77532-85-5
|
|
IMatinib iMpurity
|
伊馬替尼雜質(zhì)
|
152459-96-6
|
|
Iptazosole impurity
|
依匹唑哌雜質(zhì)
|
|
|
Afatinib impurity
|
阿法替尼雜質(zhì)
|
|
|
Methanesulfonate methanesulfonamide impurity
|
甲磺酸沙芬酰胺雜質(zhì)
|
|
|
Pabuximab impurity
|
帕布昔利布雜質(zhì)
|
|
|
6-?amino-7-[(tetrahydro-3-furanyl)oxy]-4(3H)-Quinazolinone
|
阿法替尼雜質(zhì)
|
1405180-57-5
|
|
Pabuxilibu impurities
|
帕布昔利布雜質(zhì)
|
|
|
Lenalidomide impurity (spot)
|
來那度胺雜質(zhì) (現(xiàn)貨)
|
|
|
Dipyridamole Impurity Reference
|
雙嘧達莫雜質(zhì)對照品
|
|
|
Genetically modified soybean standard
|
轉(zhuǎn)基因大豆標準品
|
|
|
Crizotinib iMpurity
|
克唑替尼雜質(zhì)
|
|
|
RaMelteon iMpurity
|
雷美替胺雜質(zhì)
|
1204581-51-0
|
|
Lurasidon hydrochloride iMpurity
|
魯拉西酮雜質(zhì)
|
1260138-03-1
|
|
Paroxetine IMpurity
|
帕羅西汀雜質(zhì)
|
|
|
Cefaclor EP IMpurity
|
頭孢克洛雜質(zhì)
|
|
|
Cefixime Impurity
|
頭孢克肟雜質(zhì)
|
33748-00-4
|
|
6,8-DIBROMO-3-CYCLOHEXYL-3,4-DIHYDRO-2(1H)-QUINAZOLINONE
|
鹽酸溴己新雜質(zhì)
|
21237-84-3
|
|
LCZ Impurity
|
LCZ696雜質(zhì)
|
753421-85-1
|